Search | Dengue Academy

Dengue Academy is intended for an international audience of healthcare professionals outside of the US and UK.
This website has been initiated and developed by Takeda

© Copyright 2025 Takeda Pharmaceutical Company Limited. All rights reserved.
Takeda and the Takeda Logo are registered trademarks of Takeda Pharmaceutical Company Limited.
VV-MEDMAT-55340, Date of preparation: November 2023

Dengue global challenges - epidemiology & clinical diagnosis

WSPID

70 minutes
Dengue in the Midst of COVID-19 Pandemic

ADVA

14 minutes
What is the diagnosis? - Challenging Pediatric ID Cases in Dengue Endemic Regions

WSPID

59 minutes
Emerging Issues in Dengue Control

Takeda
Experience of a tertiary hospital in Singapore managing a dual outbreak of COVID and dengue

Takeda

2 minutes
Case report: Acute vision loss in a young returning traveler with dengue fever

Takeda

2 minutes
Covid-19 and dengue: Double punches for dengue-endemic countries in Asia

Takeda

2 minutes
First autochthonous dengue outbreak in Italy, August 2020

Takeda

2 minutes
Dengue is the most common non-malarial febrile illness in Southern Asia and Southeastern Asia

Takeda

2 minutes
When fever is not malaria in Latin America

Takeda

2 minutes
Surveillance and Reporting

Takeda

5 minutes
Antibody Levels over Time

Takeda

2 minutes
Laboratory diagnostic tests

Takeda
Differential diagnosis

Takeda

1 minutes
Dengue disease states

Takeda

4 minutes
Burden of Dengue

Takeda

38 minutes
Challenges in the management and diagnosis of Zika, Dengue and Chikungunya

Takeda

42 minutes
Clinical diagnosis and management of dengue

PAHO
Dengue Clinical Case Management

CDC
The global trends and regional differences in incidence of dengue infection from 1990 to 2019: An analysis from the Global Burden of Disease Study 2019

Takeda

2 minutes
Antibody-dependent enhancement of severe dengue disease in humans

Takeda

2 minutes
Dengue: diagnosis and treatment updates

ISID

62 minutes
Resources for patient support

Takeda

3 minutes
Causes of fever in returning travelers: A European multicenter prospective cohort study

Takeda

2 minutes
Dengue diagnosis: unique challenges in a time of a pandemic

Medscape

15 minutes
Combination of inflammatory and vascular markers in the febrile phase of dengue is associated with more severe outcomes

Takeda

2 minutes
Zika and dengue but not chikungunya are associated with Guillain–Barré syndrome in Mexico: A case-control study

Takeda

2 minutes

Dengue Academy is intended for an international audience of healthcare professionals outside of the US and UK.
This website has been initiated and developed by Takeda

© Copyright 2025 Takeda Pharmaceutical Company Limited. All rights reserved.
Takeda and the Takeda Logo are registered trademarks of Takeda Pharmaceutical Company Limited.
VV-MEDMAT-55340, Date of preparation: November 2023